• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

immunotherapy

Posted inInfections, Pharma & Biotech

Sanofi to Make Vaccine Against Acne

by Julia Mardi December 2, 2021April 11, 2024

Acne vulgaris treatment will reach a new level of quality.

GammaDelta Therapeutics.
Posted inMergers & Acquisitions, Oncology

Takeda Bets on Promising Gamma Delta T-cell Immunotherapy

by Mark Gubar October 28, 2021September 8, 2022

UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.

Posted inAutoimmune Diseases, Clinical Trials, Metabolism

Precigen ActoBio: Innovative Treatment for Type 1 Diabetes Mellitus

by Mark Gubar June 11, 2021September 8, 2022

The autoimmune disease will be defeated by restoring immune tolerance.

Gastric cancer.
Posted inOncology, Regulatory

Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer and Esophageal Cancer

by Mark Gubar April 20, 2021September 8, 2022

Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.

Lungs.
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory

Small Cell Lung Cancer: Let Immunotherapy Help!

by Tanya von Reuss and Timur Burkhanayev April 3, 2021September 8, 2022

A deadly disease and modern pharmacological attempts to treat it.

Posts pagination

Newer posts 1 2
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×